• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿筛查:迈向统一的筛查项目和系统——执行摘要

Newborn screening: toward a uniform screening panel and system--executive summary.

出版信息

Pediatrics. 2006 May;117(5 Pt 2):S296-307. doi: 10.1542/peds.2005-2633I.

DOI:10.1542/peds.2005-2633I
PMID:16735256
Abstract

The Maternal and Child Health Bureau commissioned the American College of Medical Genetics to outline a process of standardization of outcomes and guidelines for state newborn screening programs and to define responsibilities for collecting and evaluating outcome data, including a recommended uniform panel of conditions to include in state newborn screening programs. The expert panel identified 29 conditions for which screening should be mandated. An additional 25 conditions were identified because they are part of the differential diagnosis of a condition in the core panel, they are clinically significant and revealed with screening technology but lack an efficacious treatment, or they represent incidental findings for which there is potential clinical significance. The process of identification is described, and recommendations are provided.

摘要

母婴健康局委托美国医学遗传学学会概述州新生儿筛查项目结果和指南的标准化流程,并明确收集和评估结果数据的职责,包括一份建议纳入州新生儿筛查项目的统一疾病清单。专家小组确定了29种应强制进行筛查的疾病。另外还确定了25种疾病,因为它们是核心清单中某种疾病鉴别诊断的一部分,具有临床意义且能通过筛查技术检测出来,但缺乏有效的治疗方法,或者它们代表具有潜在临床意义的偶然发现。文中描述了识别过程并提供了相关建议。

相似文献

1
Newborn screening: toward a uniform screening panel and system--executive summary.新生儿筛查:迈向统一的筛查项目和系统——执行摘要
Pediatrics. 2006 May;117(5 Pt 2):S296-307. doi: 10.1542/peds.2005-2633I.
2
Newborn screening: toward a uniform screening panel and system.新生儿筛查:迈向统一的筛查项目和系统。
Genet Med. 2006 May;8 Suppl 1(Suppl 1):1S-252S. doi: 10.1097/01.gim.0000223891.82390.ad.
3
Naming and counting disorders (conditions) included in newborn screening panels.新生儿筛查项目中包含的命名和计数障碍(病症)。
Pediatrics. 2006 May;117(5 Pt 2):S308-14. doi: 10.1542/peds.2005-2633J.
4
Impact of expanded newborn screening--United States, 2006.扩大新生儿筛查的影响——美国,2006年
MMWR Morb Mortal Wkly Rep. 2008 Sep 19;57(37):1012-5.
5
Ethical, legal and social issues in newborn screening in the United States.美国新生儿筛查中的伦理、法律和社会问题。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:52-8.
6
American Academy of Pediatrics Newborn Screening Task Force recommendations: how far have we come?美国儿科学会新生儿筛查特别工作组的建议:我们已经取得了多大进展?
Pediatrics. 2006 May;117(5 Pt 2):S194-211. doi: 10.1542/peds.2005-2633B.
7
The high price of false positives.假阳性的高昂代价。
Mol Genet Metab. 2006 Mar;87(3):180-3. doi: 10.1016/j.ymgme.2005.10.004. Epub 2005 Dec 1.
8
Practices and perceptions of long-term follow-up among state newborn screening programs.州新生儿筛查项目中的长期随访实践与认知
Pediatrics. 2006 Jun;117(6):1922-9. doi: 10.1542/peds.2005-1830.
9
Financing state newborn screening programs: sources and uses of funds.为国家新生儿筛查项目提供资金:资金来源与用途
Pediatrics. 2006 May;117(5 Pt 2):S270-9. doi: 10.1542/peds.2005-2633F.
10
National evaluation of US newborn screening system components.美国新生儿筛查系统组成部分的全国性评估。
Ment Retard Dev Disabil Res Rev. 2006;12(4):236-45. doi: 10.1002/mrdd.20124.

引用本文的文献

1
Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy.日本新生儿溶酶体贮积症和肾上腺脑白质营养不良筛查的经验。
Orphanet J Rare Dis. 2025 Jul 24;20(1):373. doi: 10.1186/s13023-025-03848-4.
2
Five years of newborn screening for Pompe, Mucopolysaccharidosis type I, Gaucher, and Fabry diseases in Oregon.俄勒冈州对庞贝氏病、I型黏多糖贮积症、戈谢病和法布里病进行五年新生儿筛查的情况。
Mol Genet Metab Rep. 2025 Apr 15;43:101221. doi: 10.1016/j.ymgmr.2025.101221. eCollection 2025 Jun.
3
Next-generation sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns.
用于新生儿遗传疾病症状前鉴定的下一代测序(NGS)技术。
Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD016118. doi: 10.1002/14651858.CD016118.
4
Tandem mass spectrometry in screening for inborn errors of metabolism: comprehensive bibliometric analysis.串联质谱法在先天性代谢缺陷筛查中的应用:综合文献计量分析
Front Pediatr. 2025 Feb 20;13:1463294. doi: 10.3389/fped.2025.1463294. eCollection 2025.
5
Obstacles to Early Diagnosis of Gaucher Disease.戈谢病早期诊断的障碍
Ther Clin Risk Manag. 2025 Jan 25;21:93-101. doi: 10.2147/TCRM.S388266. eCollection 2025.
6
Newborn Screening by DNA-First: Systematic Evaluation of the Eligibility of Inherited Metabolic Disorders Based on Treatability.基于可治疗性的DNA优先新生儿筛查:对遗传性代谢疾病资格的系统评估
Int J Neonatal Screen. 2024 Dec 28;11(1):1. doi: 10.3390/ijns11010001.
7
Using genomic databases to determine the frequency and population-based heterogeneity of autosomal recessive conditions.利用基因组数据库确定常染色体隐性疾病的发病率及基于人群的异质性。
Genet Med Open. 2024 Aug 3;2:101881. doi: 10.1016/j.gimo.2024.101881. eCollection 2024.
8
Development and validation of a novel method for evaluation of multiple islet autoantibodies in dried blood spot using dissociation-enhanced lanthanide fluorescent immunoassays technology, specific and suitable for paediatric screening programmes.利用解离增强镧系荧光免疫分析技术开发并验证一种用于评估干血斑中多种胰岛自身抗体的新方法,该方法特异且适用于儿科筛查项目。
Diabetes Obes Metab. 2025 Jan;27(1):414-418. doi: 10.1111/dom.16002. Epub 2024 Oct 21.
9
Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China.中国泉州3-甲基巴豆酰辅酶A羧化酶缺乏症的新生儿筛查与基因诊断
Mol Genet Metab Rep. 2024 Aug 2;40:101127. doi: 10.1016/j.ymgmr.2024.101127. eCollection 2024 Sep.
10
Genomic sequencing in newborn screening: balancing consent with the right of the asymptomatic at-risk child to be found.新生儿筛查中的基因组测序:平衡知情同意与发现无症状高危儿童的权利。
Eur J Hum Genet. 2025 Mar;33(2):182-188. doi: 10.1038/s41431-024-01677-w. Epub 2024 Aug 12.